Antidepressants: A Comprehensive Review of Molecular Mechanisms, US FDA Approvals Till 2025, Synthesis, Pharmacokinetics and Market Trends

Gita Chawla, Tathagata Pradhan, Nida Alam, Stanzin Kunzang, Ojasvi Gupta

Open source

DOI
10.1002/ardp.70251
Published
2026-05
Container
Archiv der Pharmazie
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ardp.70251,
  title = {Antidepressants: A Comprehensive Review of Molecular Mechanisms, US FDA Approvals Till 2025, Synthesis, Pharmacokinetics and Market Trends},
  author = {Gita Chawla and Tathagata Pradhan and Nida Alam and Stanzin Kunzang and Ojasvi Gupta},
  year = {2026},
  journal = {Archiv der Pharmazie},
  doi = {10.1002/ardp.70251},
  url = {https://doi.org/10.1002/ardp.70251}
}

RIS

TY  - JOUR
TI  - Antidepressants: A Comprehensive Review of Molecular Mechanisms, US FDA Approvals Till 2025, Synthesis, Pharmacokinetics and Market Trends
AU  - Gita Chawla
AU  - Tathagata Pradhan
AU  - Nida Alam
AU  - Stanzin Kunzang
AU  - Ojasvi Gupta
PY  - 2026
JO  - Archiv der Pharmazie
DO  - 10.1002/ardp.70251
UR  - https://doi.org/10.1002/ardp.70251
ER  - 

APA

Chawla, G., Pradhan, T., Alam, N., Kunzang, S., & Gupta, O. (2026). Antidepressants: A Comprehensive Review of Molecular Mechanisms, US FDA Approvals Till 2025, Synthesis, Pharmacokinetics and Market Trends. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70251

Source records